[휴온스바이오파마 IPO] ⑤중국 파트너 아이메이커 '양날의 검'

The company's China growth strategy depends critically on partner IMEIK, creating both opportunity and strategic risk. The lock-up period IMEIK commits to at IPO will signal partnership intentions—a 2-3 year hold demonstrates confidence in the partnership, while minimum lock-up suggests potential exit plans that could jeopardize future growth.